Evidence map›Paper›PMID 15767444›Full record

ArticleJournal of virology2005

Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines.

Naoyoshi Maeda, Wuxia Fu, Aurora Ortin, Marcelo de las Heras, Hung Fan

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Loss of ENTV-2 RNA and Point Mutation ofAdvances in virology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The cytoplasmic tail of retroviral envelope glycoproteins.Progress in molecular biology and translational science · 2015
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Naoyoshi MaedaCancer Research Institute, University of California, Irvine, Irvine, CA 92697-3900, USA.
Wuxia Fu
Aurora Ortin
Marcelo de las Heras
Hung Fan
University of California, Irvine · USUniversidad de Zaragoza · ES

Funding

Oncogenesis By Jaagsiekte Sheep RetrovirusR01CA094188 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI FAN, HUNG Y. · 2002 to 2011
$3.2M
NCI NIH HHS CA94188NCI NIH HHS R01 CA094188
6 · The paper itself

Abstract

Jaagsiekte sheep retrovirus (JSRV) is the causative agent of ovine pulmonary adenocarcinoma (OPA), a transmissible lung cancer of sheep. The virus can induce tumors rapidly, and we previously found that the JSRV envelope protein (Env) functions as an oncogene, because it can transform mammalian and avian fibroblast cell lines. (N. Maeda, Proc. Natl. Acad. Sci. USA 98:4449-4454, 2001). The molecular mechanisms of JSRV Env transformation are of considerable interest. Several reports suggested that the phosphatidylinositol 3-kinase/Akt pathway is important for transformation of mammalian fibroblasts but not for chicken fibroblasts. In this study, we found that Akt/mTOR is involved in JSRV transformation of mouse NIH 3T3 fibroblasts, because treatment with the mTOR inhibitor rapamycin reduced transformation. We also found that H/N-Ras inhibitor FTI-277 and MEK1/2 inhibitors PD98059 and U0126 strongly inhibited JSRV transformation of NIH 3T3 fibroblasts, suggesting that the H/N-Ras-MEK-mitogen-activated protein kinase (MAPK) p44/42 pathway is necessary for the transformation. In RK3E epithelial cells, the MEK1/2 inhibitors also eliminated transformation, but FTI-277 only partially inhibited transformation. It was noteworthy that p38 MAPK inhibitors enhanced JSRV transformation in both fibroblasts and epithelial cells. Treatment of transformed cells with p38 inhibitors both increased levels of phospho-MEK1/2 and phospho-p44/42 and induced rapid enhancement of the transformed phenotype. Immunohistochemical staining of tumor tissues from naturally and experimentally induced OPA and naturally occurring enzootic nasal adenocarcinoma revealed strong activation of MAPK p44/42 in all cases examined. However, p38 activation was not generally observed. These results indicate that signaling through two pathways (in particular, H/N-Ras-MEK-MAPK and, to a lesser extent, Akt-mTOR) is important for JSRV-induced transformation and that p38 MAPK has a negative regulatory effect on transformation, perhaps via MEK1/2 and p44/42.

Indexed as

Cell Transformation, ViralAnimalsButadienesCells, CulturedEnzyme InhibitorsEpithelial CellsFibroblastsFlavonoidsJaagsiekte sheep retrovirusMAP Kinase Kinase 1MAP Kinase Kinase 2MethionineMiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nitriles2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAkt1 protein, ratButadienesEnzyme InhibitorsFlavonoidsFTI 277MAP Kinase Kinase 1MAP Kinase Kinase 2MethionineMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3mTOR protein, mousemTOR protein, ratNitrilesp38 Mitogen-Activated Protein KinasesProtein KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktras ProteinsSirolimusTOR Serine-Threonine KinasesU 0126

Identifiers

PMID15767444
PMCPMC1061532
OpenAlexW2103645368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.